Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

HealthLynked (HLYK) Gross Margin (2018 - 2025)

HealthLynked (HLYK) has disclosed Gross Margin for 8 consecutive years, with 46.71% as the latest value for Q3 2025.

  • On a quarterly basis, Gross Margin rose 593.0% to 46.71% in Q3 2025 year-over-year; TTM through Sep 2025 was 53.5%, a 249.0% increase, with the full-year FY2024 number at 48.25%, down 1321.0% from a year prior.
  • Gross Margin was 46.71% for Q3 2025 at HealthLynked, down from 58.24% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 131.44% in Q4 2021 to a low of 40.78% in Q3 2024.
  • A 5-year average of 61.31% and a median of 58.84% in 2025 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: plummeted -29877bps in 2021, then soared 1207bps in 2023.
  • HealthLynked's Gross Margin stood at 131.44% in 2021, then plummeted by -63bps to 48.83% in 2022, then grew by 16bps to 56.45% in 2023, then dropped by -19bps to 45.8% in 2024, then rose by 2bps to 46.71% in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Gross Margin are 46.71% (Q3 2025), 58.24% (Q2 2025), and 59.45% (Q1 2025).